NCT00775281
- Conditions
- Chronic Pelvic Pain Syndrome, Cystitis, Cystitis, Interstitial, +13 more
- Locations
-
- Dept. of Urology, Bern University Hospital Bern, Switzerland
Clinical trial condition
Overactive Bladder
Explore clinical trials studying Overactive Bladder. Study availability and eligibility vary by location and protocol.
362 public trials
25 recruiting studies
Overactive Bladder trial results
NCT00746681
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Hradec Králové, Czechia
- Pfizer Investigational Site Prague, Czechia
- Pfizer Investigational Site Prague, Czechia
- Pfizer Investigational Site Praha 4 - Krc, Czechia
Completed
Fesoterodine Flexible Dose Study
NCT00536484
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Chandler, Arizona, United States
- Pfizer Investigational Site Peoria, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States
NCT00883818
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases, +15 more
- Locations
-
- Inha University College of Medicine Inchon, South Korea
- Kangnam St. Mary's Hospital, The Catholic University of Korea Seoul, South Korea
- Asan Medical Center, Ulsan College of Medicine Seoul, South Korea
Completed
Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms
NCT00343486
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- GSK Investigational Site Av Córdoba 2424, Buenos Aires, Argentina
- GSK Investigational Site Bahía Blanca, Buenos Aires, Argentina
- GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- GSK Investigational Site Ciudad de Buenos Aires, Buenos Aires, Argentina
NCT00903045
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
Completed
Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder
NCT00795925
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
- Locations
-
Not specified
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Schwarz RTP, North Carolina, United States
NCT00427596
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
NCT00282490
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
- Locations
-
- Department of pediatrics,Skejby Sygehus, University hospital of Aarhus Aarhus, Aarhus N, Denmark